首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   22080篇
  免费   2123篇
  国内免费   1284篇
耳鼻咽喉   198篇
儿科学   277篇
妇产科学   416篇
基础医学   2011篇
口腔科学   433篇
临床医学   2944篇
内科学   2917篇
皮肤病学   253篇
神经病学   974篇
特种医学   677篇
外国民族医学   8篇
外科学   1444篇
综合类   4474篇
现状与发展   10篇
一般理论   1篇
预防医学   2046篇
眼科学   556篇
药学   2768篇
  17篇
中国医学   1733篇
肿瘤学   1330篇
  2024年   75篇
  2023年   322篇
  2022年   797篇
  2021年   1026篇
  2020年   823篇
  2019年   609篇
  2018年   636篇
  2017年   689篇
  2016年   618篇
  2015年   971篇
  2014年   1229篇
  2013年   1280篇
  2012年   1832篇
  2011年   1920篇
  2010年   1467篇
  2009年   1241篇
  2008年   1475篇
  2007年   1362篇
  2006年   1313篇
  2005年   1110篇
  2004年   803篇
  2003年   715篇
  2002年   662篇
  2001年   496篇
  2000年   409篇
  1999年   311篇
  1998年   179篇
  1997年   186篇
  1996年   139篇
  1995年   139篇
  1994年   101篇
  1993年   67篇
  1992年   89篇
  1991年   78篇
  1990年   62篇
  1989年   53篇
  1988年   47篇
  1987年   35篇
  1986年   35篇
  1985年   17篇
  1984年   11篇
  1983年   7篇
  1982年   7篇
  1981年   7篇
  1977年   5篇
  1976年   3篇
  1975年   3篇
  1974年   3篇
  1973年   4篇
  1972年   4篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
目的探讨参龟培元颗粒对重症肌无力(myastheniagravis,MG)的治疗作用。方法采用合成电鳗乙酰胆碱受体α亚单位125-147段多肽介导的实验性自身免疫性重症肌无力(experimentalautoimmunemyastheniagravis,EAMG)大鼠模型,研究参龟培元颗粒对造模大鼠临床症状、肌电与收缩力、血清AchR-Ab滴度及细胞因子TNF-α、IFN-γ含量的影响。结果参龟培元颗粒(16.0,8.0g/kg)可明显改善大鼠的肌无力症状,降低血清AchR-Ab滴度及TNF-α、IFN-γ含量,且对低频刺激引起的造模大鼠肌电衰减和肌肉收缩力的衰减具有显著的改善作用。结论参龟培元颗粒对大鼠EAMG有一定的治疗作用。  相似文献   
52.
目的:自我干预强化点检表对前列腺手术患者自护能力与心理韧性及并发症的影响。方法:选取2019年5月~2021年6月在我院126例前列腺手术患者作为研究对象,按照随机数字表法分为对照组(予以常规护理干预)与观察组(在常规护理干预的基础上予以自我干预强化点检表),各63例,对比自我护理能力测定量表(ESCA)、心理韧性量表;观察并发症(尿路感染、尿道狭窄、尿潴留、尿失禁、尿频)。结果:入院时,两组患者 ESCA评分、心理韧性评分(坚韧、乐观、自强)比较差异无统计学意义;出院后3个月,观察组的ESCA评分、心理韧性评分(坚韧、乐观、自强)高于对照组。观察组患者的并发症总发生率低于对照组。结论:自我干预强化点检表有利于提高前列腺手术患者的自护能力与心理韧性,以及降低并发症发生率。  相似文献   
53.
Background:The aim of this study was to investigate the clinical effect and safety of accelerated-strategy initiation of renal replacement therapy (RRT) in critically ill patients.Methods:PubMed, Embase, OVID, EBSCO, and the Cochrane Library databases were searched for relevant articles from inception to December 30, 2020. Only RCTs that compared the clinical efficacy and safety between accelerated-strategy RRT and standard-strategy RRT among critically ill adult patients with acute kidney injury (AKI) were included. The primary outcome was 28-day mortality.Results:A total of 5279 patients in 12 RCTs were included in this meta-analysis. The 28-day mortality rates of patients treated with accelerated and standard RRT were 37.3% (969/2596) and 37.9% (976/2573), respectively. No significant difference was observed between the groups (OR, 0.92; 95% CI, 0.70–1.12; I2 = 60%). The recovery rates of renal function were 54.5% and 52.5% in the accelerated- and standard-RRT groups, respectively, with no significant difference (OR, 1.03; 95% CI, 0.89–1.19; I2 = 56%). The rate of RRT dependency was similar in the accelerated- and standard-RRT strategies (6.7% vs 5.0%; OR, 1.11; 95% CI, 0.71–1.72; I2 = 20%). The accelerated-RRT group displayed higher risks of hypotension, catheter-related infection, and hypophosphatemia than the standard-RRT group (hypotension: OR, 1.26; 95% CI, 1.10–1.45; I2 = 36%; catheter-related infection: OR, 1.90; 95% CI, 1.17–3.09; I2 = 0%; hypophosphatemia: OR, 2.11; 95% CI, 1.43–3.15; I2 = 67%).Conclusions:Accelerated RRT does not reduce the risk of death and does not improve the recovery of kidney function among critically ill patients with AKI. In contrast, an increased risk of adverse events was observed in patients receiving accelerated RRT. However, these findings were based on low quality of evidence. Further large-scale RCTs is warranted.  相似文献   
54.
In this study, the effect of pH shock during the treatment of sulfate-containing organic wastewater was investigated using an anaerobic fermentation system reinforced with graphene oxide (GO)/iron series systems. The results show that the anaerobic system with the GO/iron series systems exhibited enhanced resistance to pH shock. Among them, the GO/Fe0 system had the strongest resistance to pH shock, the systems of GO/Fe3O4 and GO/Fe2O3 followed close behind, while the blank system performed the worst. After pH shock, the CODCr removal rate, SO42− removal rate, and gas production of the GO/Fe0 group were significantly improved compared with those of the control group by 51.0%, 65.3%, and 34.6%, respectively, while the accumulation of propionic acid was the lowest. Further, detailed microbial characterization revealed that the introduction of the GO/iron series systems was beneficial to the formation of more stable anaerobic co-metabolic flora in the system, and the relative abundance of Geobacter, Clostridium, Desulfobulbus and Desulfovibrio increased after acidic and alkaline shock.

In this paper, we studied the pH shock resistance mechanism of GO/iron series from the perspectives of the treatment effect, changes in effluent pH and VFA, and microbial co-metabolic stability, providing a reference for the practical application.  相似文献   
55.
Cardiovascular disease (CVD) is a group of diseases affecting the heart and blood vessels and is the leading cause of morbidity and mortality worldwide. Increasingly more evidence has shown that the senescence of vascular endothelial cells is the key to endothelial dysfunction and cardiovascular diseases. Anthocyanin is a type of water-soluble polyphenol pigment and secondary metabolite of plant-based food widely existing in fruits and vegetables. The gut microbiome is involved in the metabolism of anthocyanins and mediates the biological activities of anthocyanins and their metabolites, while anthocyanins also regulate the growth of specific bacteria in the microbiota and promote the proliferation of healthy anaerobic flora. Accumulating studies have shown that anthocyanins have antioxidant, anti-inflammatory, and anti-aging effects. Many animal and in vitro experiments have also proven that anthocyanins have protective effects on cardiovascular-disease-related dysfunction. However, the molecular mechanism of anthocyanin in eliminating aging endothelial cells and preventing cardiovascular diseases is very complex and is not fully understood. In this systematic review, we summarize the metabolism and activities of anthocyanins, as well as their effects on scavenging senescent cells and cardioprotection.  相似文献   
56.
The effects of organophosphorus pesticides (OPs), oxons and their ozonation byproducts on gap junctional intercellular communication (GJIC) on cultured BRL cell line were investigated using scrape loading and dye transfer (SL/DT) technique. The neutral red uptake assay was used to identify the non-cytotoxic levels of diazinon, parathion and methyl-parathion applied to GJIC assay. The concentration-dependent inhibition of GJIC was observed over a range of 50-350 mg/l diazinon, parathion and methyl-parathion after 90 min incubation compared with the vehicle control. However, oxons and ozonation byproducts of OPs had no inhibition effect on GJIC at any of the concentrations tested. The inhibition of GJIC by OPs was reversible after removal of the tested pesticides followed by incubation with fresh medium. The present study suggested that the ozonation treatment could be used for the detoxification of drinking water and food crops contaminated with diazinon, parathion and methyl-parathion without formation of GJIC toxicity.  相似文献   
57.
目的 设计合成了一组新的N-羟基肉桂酰胺类衍生物并测定其对组蛋白去乙酰化酶(HDACs)的抑制活性.方法 以阿魏酸为原料,经酯化、Williamson反应、皂化、缩合4步反应合成了一组新的N-羟基肉桂酰胺类衍生物;用组蛋白去乙酰化酶活性检测试剂盒测定该组化合物体外抑酶活性.结果 与结论 合成了11个未见文献报道的N-羟基肉桂酰胺类衍生物,其结构经过1H-NMR、MS、和IR确认.其中化合物5a、5b、5e和5k的体外抑酶活性较强(IC50=2~15μmol·L-1),有可能具有抗肿瘤活性,值得进一步研究.  相似文献   
58.
59.
随着现代科学技术的发展,网络逐渐走进越来越多人的生活。网络就像一把双刃剑,给人们的生活带来快捷的同时,也严重的影响着人们。由此伴生的网络成瘾问题也越来越成为一种显著的社会问题。网络成瘾是一种疾病,然而目前对其研究较多的则是从心理学角度加以认识和干预。文章主要概述了网络成瘾的现状,发病的生物化学机制以及生物医学、心理学、药物、针灸等治疗方法与现状,并对存在的问题和今后的研究方向加以总结和探讨。以对今后的治疗提供参考。  相似文献   
60.
目的探讨中西医结合治疗急性胰腺炎(AP)伴胃肠功能障碍的临床疗效。方法回顾性分析377例AP临床资料,按治疗方法分为中西医结合组和西医组,对比分析2组胃肠功能改善的差异性。结果中西医结合组在腹胀缓解时间、自主排便好转时间、肠鸣音好转时间方面均优于西医组,差异有统计学意义(P〈0.05)。结论中西医结合治疗可显著改善AP患者的胃肠功能。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号